A new surveillance gynecological network to assess the incidence and prevalence of genital warts in the Italian female population: Lessons learned

Minerva Ginecologica

Volumn 65, Issue 5, 2013, Pages 577-585

  Suligoi, B ^a   Salfa, M C ^a   Mariani, L ^b   Corsini, D ^c   Timelli, L ^c   Fattorini, G ^d   Vittori, G ^e  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c Informasrl   (Italy)

^d Pneumologia Territoriale   (Italy)

^e Divisione di Medicina Interna   (Italy)

Author keywords

Female; Incidence; Italy; Prevalence

Indexed keywords

CONDYLOMA ACUMINATUM; DISEASE SURVEILLANCE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; INCIDENCE; ITALY; MALE; PILOT STUDY; PREVALENCE; REVIEW; SEXUALLY TRANSMITTED DISEASE; WART VIRUS;

ADOLESCENT; ADULT; CONDYLOMATA ACUMINATA; FEMALE; GYNECOLOGY; HUMANS; INCIDENCE; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POPULATION SURVEILLANCE; PREVALENCE; REPRODUCIBILITY OF RESULTS; SEXUALLY TRANSMITTED DISEASES; YOUNG ADULT;

EID: 84890830358     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Fairley CK, Gay NJ, Forbes A, Abramson M, Garland SM. Hand-genital transmission of genital warts? An analysis of prevalence data. Epidemiol. Infect 1995;115:169-76.
2. Burchell AN, Winner RL, de Sanjose S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24(Suppl 3):52-61.
3. Giles S. Transmission of HPV. CMAJ 2003; 168:1.391.
4. Bosch FX, Qiao YL, Castellsanguè X. The epidemiology of human papillomavirus infection and its association with cervical cancer. Int J Gynecol Obstetr 2006;94(Suppl. 1):8-21.
5. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intrepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64. (Pubitemid 23177581)
6. Chinchai T, Chansenroj J, Swangvaree S, Junyangdikul P, Poovorawan Y. Prevalence of human papillomavirus genotypes in cervical cancer. Int J Gynecol Cancer 2012;22:1063-8.
7. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Epidemiology and burden of HPV infection and related diseases : implications for prevention strategies. Prev Med. 2011;53(Suppl 1):S12-21.
8. Meyer T, Arndt R, Christophers E, Beckmann ER, Schroder S, Gissmann L et al. Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infec Dis 1998;178:252-5. (Pubitemid 28328102)
9. Brown DR, Schroeder JM, Bryan JM, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999;37:316-22.
10. Stanley MA. Genital human papillomavirus infections: current and prospective therapies. J Gen Virol 2012;93(Pt 4):681-91.
11. Blomberg M, Friis S, Munk C, Bautz A, Kjer S. Genital warts and risk of cancer- a Danish study of nearly 50,000 patients with genital warts. J Infect Dis 2012;205:1.544-53.
12. Hartwig S, Syrjanen S, Dominiak-Felden G, Brontons M, Castellsague X. Estimation of the epidemiological burden of human papillomavirus-related cancers and non malignant diseases in men in Europe: a review. BMC Cancer 2012;12:30.
13. Health Protection Agency. Trends in genital warts and genital herpes diagnoses in the United Kingdom. Health Protection Report 2007;1.
14. Salfa MC, Regine V, Ferri M, Pugliese L, Suligoi B e la Rete Sentinella dei Centri Clinici per le Malattie Sessualmente Trasmesse. La Sorveglianza delle Malattie Sessualmente Trasmesse basata su una rete di centri clinici: 18 anni di attività. Not Ist Super Sanita 2012;25:3-10.
15. Vaccaro MC. I comportamenti e le conoscenze generali sulla salute riproduttiva. Le donne italiane e la prevenzione dell'HPV. La conoscenza delle patologie da Papillomavirus umano e la propensione alla vaccinazione. Indagine Censis 2011, pag. 15-19.
16. Ukoumunne OC, Guilford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technol Assess 1999;3:iii-92.
17. Campbell MK, Fayers PM, Grimshaw JM. Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research. Clin Trials 2005;2:99-107. (Pubitemid 40637892)
18. Yelland LN, Salter AB, Ryan P, Laurence CO. Adjusted intraclass correlation coefficients for binary data: methods and estimates from a cluster-randomized trial in primary care. Clin Trials 2011;8:48-58.
19. Corsini D. Personal communication based on data collected by Indagine multiscopo sulle famiglie - Condizioni di salute e ricorso ai servizi sanitari 2004-2005; www.istat.it/it/archivio/7740.
20. Ukoumunne OC, Guilford MC, Chinn S, Sterne JAC, Burney PGJ. Methods between-cluster variation. Health Technol Assess 1999;3:iii-92.
21. Parker DR, Evangelou E, Eaton CB. Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART).
22. Vittori G, Mateelli A, Boselli F, Naldi L, Emberti Gialloreti L. A new approach to estimate genital warts incidence and prevalence in the italian general female population. It J Gynaecol Obstet 2008;20:33-42. (Pubitemid 351802376)
23. Digs n. 196 del 30 giugno 2003. Codice in materia di protezione dei dati personali.
24. Desai S, Wetten S, Woodhall SC, Peters L, Hughes G, Soldan K. Sex Genital warts and cost of care in England. Sex Transm Infect 2011;87:464-8.
25. Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E et al. The Burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007;196:1.447-54.
26. Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national HPV vaccination programme. Sex Transm Infect 2011;87:544-7.
27. Bauer HM, Wright G, Chow J. Evidence of Human Papillomavirus vaccine-effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010. Am J Public Health 2012;102:833-5.
28. Oliphant J, Perkins N. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland sexual health services. N Z Med J 2011;124:51-8.